• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母体苯丙酮尿症中脑发育不全的磁共振成像特征

MRI characterization of cerebral dysgenesis in maternal PKU.

作者信息

Allen R J, Brunberg J, Schwartz E, Schaefer A M, Jackson G

机构信息

Division of Pediatric Neurology, University of Michigan Medical School, Ann Arbor, USA.

出版信息

Acta Paediatr Suppl. 1994 Dec;407:83-5. doi: 10.1111/j.1651-2227.1994.tb13460.x.

DOI:10.1111/j.1651-2227.1994.tb13460.x
PMID:7766967
Abstract

MPKU pregnancies, with or without dietary treatment to reduce maternal plasma phenylalanine (phe), show variable, increased non-physiologic levels, as the putative cause of fetal teratogenicity. Cerebral dysgenesis with clinical neonatal microcephaly and congenital heart disease indicates altered organ morphogenesis. Although there is not an established precise relationship between maternal phe levels and outcome, dietary restriction before or early in gestation is universally advised. Both human experience and animal research have suggested differential organ responses to high and low phe levels. Structural microencephaly may be due to reduced brain volume or abnormal regional brain development. Infants in MPKU are also at risk to develop PKU. Microencephaly was evident by MRI in 8 of 21 infants born to 12 MPKU mothers; 2 infants of one mother developed PKU. All levels of gestational plasma phe were associated with otherwise structurally normal infant microencephalic brains appropriate for age in myelination. CHD occurred in one microencephalic infant of a classic MPKU treated in the first trimester. Maternal, cord and neonatal plasma phenylalanine at delivery did not correlate with teratogenic effects. Only untreated 'classic' MPKU fetal effects appear predictable.

摘要

患有苯丙酮尿症(PKU)的孕妇,无论是否接受饮食治疗以降低母体血浆苯丙氨酸(phe)水平,都会出现可变的、非生理性升高的水平,这被认为是胎儿致畸性的原因。伴有临床新生儿小头畸形和先天性心脏病的脑发育不全表明器官形态发生改变。尽管母体苯丙氨酸水平与结局之间尚未建立精确的关系,但普遍建议在妊娠前或妊娠早期进行饮食限制。人类经验和动物研究均表明,不同器官对高苯丙氨酸水平和低苯丙氨酸水平的反应不同。结构性小头畸形可能是由于脑容量减少或局部脑发育异常所致。患有苯丙酮尿症的婴儿也有患苯丙酮尿症的风险。在12名患有苯丙酮尿症的母亲所生的21名婴儿中,有8名婴儿通过MRI检查发现明显的小头畸形;一位母亲的2名婴儿患了苯丙酮尿症。所有妊娠血浆苯丙氨酸水平均与在髓鞘形成方面与年龄相符的结构正常的婴儿小头畸形脑有关。一名在孕早期接受治疗的典型苯丙酮尿症患者所生的小头畸形婴儿患有先天性心脏病(CHD)。分娩时母体、脐带和新生儿血浆苯丙氨酸水平与致畸作用无关。只有未经治疗的“典型”苯丙酮尿症胎儿的影响似乎是可预测的。

相似文献

1
MRI characterization of cerebral dysgenesis in maternal PKU.母体苯丙酮尿症中脑发育不全的磁共振成像特征
Acta Paediatr Suppl. 1994 Dec;407:83-5. doi: 10.1111/j.1651-2227.1994.tb13460.x.
2
[The maternal phenylketonuria syndrom--still current problem].[母体苯丙酮尿症综合征——仍然是当前的问题]
Przegl Lek. 2009;66(1-2):4-10.
3
Role of nutrition in pregnancy with phenylketonuria and birth defects.营养在苯丙酮尿症妊娠及出生缺陷中的作用。
Pediatrics. 2003 Dec;112(6 Pt 2):1534-6.
4
Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy.孕期母体高苯丙氨酸水平对4岁和6岁子代先天性异常及发育结局的影响:孕前及整个孕期严格饮食控制的重要性
J Pediatr. 2004 Feb;144(2):235-9. doi: 10.1016/j.jpeds.2003.10.062.
5
A case of maternal phenylketonuria syndrome presenting with unilateral renal agenesis.一例表现为单侧肾发育不全的母源性苯丙酮尿症综合征。
J Trop Pediatr. 2011 Apr;57(2):138-40. doi: 10.1093/tropej/fmq062. Epub 2010 Jul 1.
6
Maternal Phenylketonuria International Collaborative Study revisited: evaluation of maternal nutritional risk factors besides phenylalanine for fetal congenital heart defects.重新审视母源性苯丙酮尿症国际合作研究:评估除苯丙氨酸以外的母体营养风险因素对胎儿先天性心脏缺陷的影响。
J Inherit Metab Dis. 2014 Jan;37(1):39-42. doi: 10.1007/s10545-013-9627-x. Epub 2013 Jun 20.
7
[Embryonic pathology caused by maternal phenylketonuria. A cause of underdiagnosed mental retardation. A report of 8 cases].[母体苯丙酮尿症所致胚胎病理学。智力发育迟缓诊断不足的一个原因。8例报告]
An Esp Pediatr. 1999 Aug;51(2):139-42.
8
Maternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae.母体苯丙酮尿症协作研究(MPKUCS)后代:面部异常、畸形及早期神经后遗症。
Am J Med Genet. 1997 Mar 3;69(1):89-95. doi: 10.1002/(sici)1096-8628(19970303)69:1<89::aid-ajmg17>3.0.co;2-k.
9
The international collaborative study of maternal phenylketonuria: status report 1994.母体苯丙酮尿症国际合作研究:1994年现状报告
Acta Paediatr Suppl. 1994 Dec;407:111-9. doi: 10.1111/j.1651-2227.1994.tb13468.x.
10
Maternal phenylketonuria: a metabolic teratogen.母体苯丙酮尿症:一种代谢性致畸物。
Teratology. 1996 Mar;53(3):176-84. doi: 10.1002/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2.

引用本文的文献

1
Maternal Phenylketonuria and Offspring Outcome: A Retrospective Study with a Systematic Review of the Literature.母体苯丙酮尿症与子代结局:一项回顾性研究及文献系统综述
Nutrients. 2025 Feb 14;17(4):678. doi: 10.3390/nu17040678.
2
Neurometabolic disorders and congenital malformations of the central nervous system.神经代谢紊乱与中枢神经系统先天性畸形。
Neurosciences (Riyadh). 2018 Apr;23(2):97-103. doi: 10.17712/nsj.2018.2.20170481.